Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
SIRT1, Mitochondrial Biogenesis, and Prion Toxicity
2026-08-30
Zhao and colleagues identify a SIRT1–PGC-1α–TFAM pathway that links prion peptide toxicity to impaired mitochondrial biogenesis in N2a neuroblastoma cells. Their findings show that SIRT1 activation, including pharmacological activation by Resveratrol, can improve mitochondrial integrity and reduce apoptosis, while also defining important limits for translation beyond this cellular model.
-
Dual-Metric In Vitro Evaluation of Cancer Drug Responses
2026-08-29
Hannah R. Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. Its central contribution is a dual-metric framework that separates proliferative arrest from cell death, improving interpretation of dose and time-dependent responses in cancer biology research.
-
Quercetin Protects Cataract Lenses via Hippo Signaling
2026-08-28
The reference study identifies Hippo pathway modulation as a potential mechanism through which quercetin protects lens epithelial cells from oxidative cataract injury. By combining network pharmacology with UVB-induced cataract models, H2O2-injured cells, and α-hederin rescue experiments, it links reduced oxidative stress and improved epithelial survival to Hippo pathway suppression.
-
Sorafenib (BAY-43-9006) Workflow Guide
2026-08-28
Build cleaner oncology assays with Sorafenib by separating direct tumor-cell effects from VEGFR-linked antiangiogenic activity. This workflow combines dose-response design, endothelial tube formation, pathway readouts, and reference-study benchmarking for more interpretable cancer biology research.
-
GS967: Cardiac Late Sodium Current Inhibitor
2026-08-27
GS967 supports a connected workflow from ventricular myocyte sodium-current recording to calcium handling, repolarization, and whole-heart arrhythmia assays. Its concentration- and voltage-dependent activity makes it useful for testing whether pathological late sodium influx is a causal driver rather than merely a correlate of cardiac dysfunction.
-
Fludarabine: Designing Decision-Grade DNA Assays
2026-08-27
Fludarabine is a DNA synthesis inhibitor that can do more than establish cytotoxicity in oncology models. This guide presents a decision-grade assay framework linking replication stress, apoptosis, genotype-aware model selection, and translational interpretation.
-
Cannabis Terpenes Activate A2A Receptors in Neuropathic Pain
2026-08-26
Schwarz et al. show that several Cannabis sativa terpenes reduce pain-related behavior in mouse models of chemotherapy-induced neuropathy and inflammatory pain through an adenosine A2A receptor-dependent mechanism. The combination of behavioral pharmacology, spinal CRISPR knockdown, cAMP and binding assays, and molecular modeling provides a mechanistic framework for evaluating non-cannabinoid terpene analgesia.
-
NPT1-Mediated PAH Transport and Faropenem
2026-08-26
The reference study provided the first molecular evidence that human renal NPT1 can transport p-aminohippuric acid (PAH) across the apical membrane of proximal-tubule cells. Its chloride sensitivity, substrate inhibition profile, and recognition of faropenem connect phosphate-transporter biology with renal handling of organic anions, while also defining important limits for interpreting antibiotic experiments.
-
Peptidisc-Assisted Multimeric Nanobody Engineering
2026-08-25
Chen and Duong van Hoa describe a peptidisc-assisted hydrophobic clustering strategy that converts engineered nanobodies into soluble multimeric, bispecific, and autofluorescent assemblies. The preprint links multivalency to stronger functional binding and suggests a modular alternative to tandem fusion, self-assembly domains, and chemical cross-linking.
-
Sulfo-NHS-SS-Biotin: Cell-Surface Workflows
2026-08-24
Build reversible protein-labeling workflows for surface proteomics, affinity capture, and validation of cell-surface interactions. The kit combines water-compatible NHS-ester chemistry with disulfide cleavage, enabling selective labeling, enrichment, and controlled release from streptavidin.
-
Vorinostat: HDAC Inhibition and Apoptosis
2026-08-24
Vorinostat, also called suberoylanilide hydroxamic acid or SAHA, is a small-molecule histone deacetylase inhibitor used in cancer biology research. Its reported HDAC potency, cell-growth effects, formulation limits, and relationship to emerging RNA Pol II apoptosis biology require assay-specific interpretation.
-
AMD-070 Hydrochloride: CXCR4 Research Workflows
2026-08-23
Build reproducible CXCR4 migration, immune-cell, and translational assays with AMD-070 hydrochloride, while separating practical screening conditions from clinical evidence. The workflow also clarifies when WHIM and Waldenström macroglobulinemia models can inform antiviral hypotheses without overstating maturity.
-
Cy7 NHS Ester: Practical Labeling and QC
2026-08-22
Cy7 NHS ester provides a water-compatible route for attaching a near-infrared fluorophore to accessible amino groups on proteins, peptides, and related biomolecules. It is useful for aqueous labeling and imaging workflows, but it should not be selected for long-term storage of prepared dye solutions, strictly non-aqueous reactions, or applications requiring unvalidated in vivo performance.
-
Sulfo-Cy3 NHS Ester for Reliable Cell Assays
2026-08-21
Learn how Sulfo-Cy3 NHS ester, SKU A8107, can support reproducible protein labeling, uptake studies, and fluorescence controls around cell viability and vascular biology assays. This scenario-based guide separates biomolecule tracing from viability readouts and translates product specifications into practical laboratory decisions.
-
Tetraethylammonium Chloride: Assay Logic
2026-08-20
Tetraethylammonium chloride is more than a potassium-channel blocker: it is a mechanistic perturbation tool for separating pore conductance from downstream physiology. This guide translates ion-flux, patch-clamp, vascular, and secretory evidence into better assay controls and interpretation.